{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T11:41:10Z","timestamp":1778758870579,"version":"3.51.4"},"reference-count":5,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.ophtha.2019.10.032","type":"journal-article","created":{"date-parts":[[2020,2,19]],"date-time":"2020-02-19T01:01:32Z","timestamp":1582074092000},"page":"e19","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Re: Van Asten et\u00a0al.: No CFH\/ARMS2 interaction with omega-3 fatty acids, low vs high zinc, or \u03b2-carotene versus Lutein and Zeaxanthin on progression of age-related\u00a0macular degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report No. 18 (Ophthalmology. 2019;126:1541-1548)"],"prefix":"10.1016","volume":"127","author":[{"given":"Brent","family":"Zanke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafal","family":"Kustra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2019.10.032_bib1","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.ophtha.2019.06.004","article-title":"No CFH\/ARMS2 interaction with omega-3 fatty acids, low vs high zinc, or \u03b2-carotene versus lutein\/zeaxanthin on progression of age-related macular degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 (AREDS2) Report No. 18","volume":"126","author":"van Asten","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2019.10.032_bib2","article-title":"A\u00a0randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8","volume":"119","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2019.10.032_bib3","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1136\/bjophthalmol-2016-308624","article-title":"Response to AREDS supplements according to genetic factors: survival analysis approach using the eye as the unit of analysis","volume":"100","author":"Seddon","year":"2016","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2019.10.032_bib4","doi-asserted-by":"crossref","first-page":"E696","DOI":"10.1073\/pnas.1718059115","article-title":"CFH and ARMS2 genetic risk determines progression to neovascular age-related macular degeneration after antioxidant and zinc supplementation","volume":"115","author":"Vavvas","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ophtha.2019.10.032_bib5","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1016\/j.ophtha.2017.12.018","article-title":"Re: Assel et\u00a0al.: Genetic polymorphisms of CFH and ARMS2 do not predict response to antioxidants and zinc in\u00a0patients with age-related macular degeneration. (Ophthalmology. 2018;125:391-397)","volume":"125","author":"Zanke","year":"2018","journal-title":"Ophthalmology"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642019321906?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642019321906?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T14:08:20Z","timestamp":1758982100000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642019321906"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":5,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S0161642019321906"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2019.10.032","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Re: Van Asten et\u00a0al.: No CFH\/ARMS2 interaction with omega-3 fatty acids, low vs high zinc, or \u03b2-carotene versus Lutein and Zeaxanthin on progression of age-related\u00a0macular degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report No. 18 (Ophthalmology. 2019;126:1541-1548)","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2019.10.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2019.06.004","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}